Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS
Content archived on 2024-05-27

Mutant p53 gain of function activities as determinants for tumor prognosis and therapy

Objective

P53 gene mutations are common in cancer. Human tumors accumulate abundant mutant p53 protein. Wild type (wt) p53 is a potent tumor supressor. In addition to loosing the inhibitory functions of wt p53, cancer-associated mutant p53 may gain new oncogenic functions to actively promote cancer. Wt p53 is studied extensively, but little is known about gain of function of mutant p53 and its relevance to cancer. Based on recent findings by the partners, we will explore biological effects of tumor-derived p53 mutants and their biochemical basis. We will use cell-free assays, cultured cells and mouse models. Different mutants will be compared. A special database will address correlations between mutant p53 status and patient outcome. Using a novel assay, chemical libraries will be screened for p53-inhibitory drugs. This should advance understanding of cancer etiology and define new therapy taegets.

Fields of science (EuroSciVoc)

CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.

You need to log in or register to use this function

Topic(s)

Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.

Call for proposal

Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.

Data not available

Funding Scheme

Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.

CSC - Cost-sharing contracts

Coordinator

HEINRICH-PETTE-INSTITUT FUER EXPERIMENTELLE VIROLOGIE UND IMMUNOLOGIE AN DER UNIVERSITAET HAMBURG
EU contribution
No data
Total cost

The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.

No data

Participants (5)

My booklet 0 0